Geron Corp
NASDAQ:GERN

Watchlist Manager
Geron Corp Logo
Geron Corp
NASDAQ:GERN
Watchlist
Price: 1.51 USD -2.58% Market Closed
Market Cap: 961.7m USD

Wall Street
Price Targets

GERN Price Targets Summary
Geron Corp

Wall Street analysts forecast GERN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GERN is 3.76 USD with a low forecast of 1.52 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.52 USD
0% Upside
Average
Price Target
3.76 USD
149% Upside
Highest
Price Target
6.3 USD
317% Upside
Geron Corp Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
51% Upside
SVE
Synthaverse SA
37% Upside
BIIB
Biogen Inc
36% Upside
TGTX
TG Therapeutics Inc
20% Upside
302440
SK Bioscience Co Ltd
22% Downside
688366
Shanghai Haohai Biological Technology Co Ltd
47% Upside
VIR
Vir Biotechnology Inc
259% Upside
REGN
Regeneron Pharmaceuticals Inc
47% Upside

Revenue
Forecast

Revenue Estimate
Geron Corp

For the last 8 years the compound annual growth rate for Geron Corp's revenue is 37%. The projected CAGR for the next 3 years is 79%.

37%
Past Growth
79%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Geron Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Geron Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GERN's stock price target?
Price Target
3.76 USD

According to Wall Street analysts, the average 1-year price target for GERN is 3.76 USD with a low forecast of 1.52 USD and a high forecast of 6.3 USD.

What is Geron Corp's Revenue forecast?
Projected CAGR
79%

For the last 8 years the compound annual growth rate for Geron Corp's revenue is 37%. The projected CAGR for the next 3 years is 79%.

Back to Top